# Medical Microinstruments

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medical-microinstruments

- Industry: Medical Devices & Equipment
- Headquarters: Pisa, Italy
- Website: www.mmimicro.com
- Total disclosed funding: $215M
- Latest round: Series C (Feb 16, 2024)
- Investors on record: 9

## About

Founded in 2015 by co-founders Giuseppe Prisco, Hannah Teichmann, and Massimiliano Simi and based in Pisa, Italy, Medical Microinstruments, Inc. is the developer of symani surgical system, a medical device that uses robotics for microsurgery. In February 2024, Medical Microinstruments, Inc. raised USD 110 million in Series C funding led by investor Fidelity Investments, with participation from investors Andera Partners, BioStar Capital, Fountain Healthcare Partners, RA Capital Management, Panakès Partners, Samba Tech SA, and Wellington Partners. As of July 2024, the company is led by CEO Mark Toland.
 
Medical Microinstruments, Inc. offers a symani surgical system. This robotic platform is designed to assist surgeons in performing microsurgical procedures with enhanced precision and control. The system features tremor reduction, motion scaling, and an ergonomic design that reduces surgeon fatigue. The Symani Surgical System is used in a variety of clinical applications, including breast cancer surgery, lymphedema treatment, head and neck cancer surgery, and trauma surgery.
 
The company will use the February 2024 funding for the expansion of its robotic-assisted microsurgery solutions and global commercialization efforts.

## Funding rounds

- Series C, Feb 16, 2024, $103M — Wellington Partners, Andera Partners, BioStar Capital, Fountain Healthcare Partners, Fidelity Investments, Deerfield Management, RA Capital Management, Samba Tech SA, Panakes Partners
- Series B, Jan 30, 2023, $12M — Wellington Partners, BioStar Capital
- Series B, Mar 30, 2022, $75M — Andera Partners, BioStar Capital, Fountain Healthcare Partners, Deerfield Management, RA Capital Management, Samba Tech SA, Panakes Partners
- Series A, Apr 18, 2018, $25M — Andera Partners, Fountain Healthcare Partners, Samba Tech SA, Panakes Partners

## Investors

- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series A, Series B, Series C
- Fountain Healthcare Partners (https://capitalatlas.ai/funds/fountain-healthcare-partners) — Series A, Series B, Series C
- Samba Tech SA — Series A, Series B, Series C
- Panakes Partners (https://capitalatlas.ai/funds/panakes-partners) — Series A, Series B, Series C
- BioStar Capital (https://capitalatlas.ai/funds/biostar-capital) — Series B, Series C
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series B, Series C
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series B, Series C
- Wellington Partners (https://capitalatlas.ai/funds/wellington-partners) — Series B, Series C
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series C